Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...
In a recent exclusive interview, Fierce Biotech’s Chris Hayden sat down with Alex MacDonald, Vice President of Model-Informed Drug Development at Allucent, to explore the impact of Project Optimus, an ...
AI-driven solutions can optimize specialty drug billing, reducing costs and enhancing financial efficiency in managed care. An AI algorithm identifies cost-effective billing methods by comparing ...
Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.
Recent Trends and Patient Outcomes of Phase I Trials: A Single-Institution Experience in the Era of New Therapeutic Agents This study reviewed all industry-sponsored phase I clinical trial protocols ...
Drug discovery is a highly specialized, multidisciplinary effort involving a wide range of scientific disciplines. Over the last few centuries, and particularly in the 20th century, drug discovery has ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback